108 related articles for article (PubMed ID: 3971348)
1. Brain microsomal enzyme mediated covalent binding of benzo[a]pyrene to DNA.
Das M; Srivastava SP; Seth PK; Mukhtar H
Cancer Lett; 1985 Jan; 25(3):343-50. PubMed ID: 3971348
[TBL] [Abstract][Full Text] [Related]
2. Clotrimazole, an inhibitor of epidermal benzo(a)pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon.
Mukhtar H; Del Tito BJ; Das M; Cherniack EP; Cherniack AD; Bickers DR
Cancer Res; 1984 Oct; 44(10):4233-40. PubMed ID: 6088034
[TBL] [Abstract][Full Text] [Related]
3. Formation in isolated rat liver microsomes and nuclei of benzo(a)pyrene metabolites that bind to DNA.
Jernström B; Vadi H; Orrenius S
Cancer Res; 1976 Nov; 36(11 Pt 1):4107-13. PubMed ID: 10077
[TBL] [Abstract][Full Text] [Related]
4. Epidermal benzo[a]pyrene metabolism and DNA-binding in Balb/C mice: inhibition by ellagic acid.
Mukhtar H; Das M; Del Tito BJ; Bickers DR
Xenobiotica; 1984 Jul; 14(7):527-31. PubMed ID: 6506765
[TBL] [Abstract][Full Text] [Related]
5. Influence of protein and RNA synthesis inhibitors on methylcholanthrene-mediated induction of aryl hydrocarbon hydroxylase activity in intestinal mucosa.
Al-Turk WA; Hassing JM; Stohs SJ
Pharmacology; 1988; 37(6):403-11. PubMed ID: 2469089
[TBL] [Abstract][Full Text] [Related]
6. Modulation of carcinogen metabolism and DNA interaction by calcium glucarate in mouse skin.
Gupta KP; Singh J
Toxicol Sci; 2004 May; 79(1):47-55. PubMed ID: 14976333
[TBL] [Abstract][Full Text] [Related]
7. Epidermis: the major site of cutaneous benzo(a)pyrene and benzo(a)pyrene 7,8-diol metabolism in neonatal BALB/c mice.
Das M; Bickers DR; Mukhtar H
Drug Metab Dispos; 1986; 14(6):637-42. PubMed ID: 2877819
[TBL] [Abstract][Full Text] [Related]
8. Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
Salhab AS; James MO; Wang SL; Shiverick KT
Drug Metab Dispos; 1986; 14(4):471-6. PubMed ID: 2873995
[TBL] [Abstract][Full Text] [Related]
9. Relationship between activities of cytochrome P-450 monooxygenases in human placental microsomes and binding of benzo(a)pyrene metabolites to calf thymus DNA.
Kim SY; Chung JH; Kang KW; Joe CO; Park KH
Drug Chem Toxicol; 1992; 15(4):313-27. PubMed ID: 1459043
[TBL] [Abstract][Full Text] [Related]
10. Formation of benzo[a]pyrene-DNA adducts by microsomal enzymes: comparison of maternal and fetal liver, fetal hematopoietic cells and placenta.
Salhab AS; James MO; Wang SL; Shiverick KT
Chem Biol Interact; 1987 Mar; 61(3):203-14. PubMed ID: 3568191
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of epidermal metabolism and DNA-binding of benzo[a]pyrene by ellagic acid.
Del Tito BJ; Mukhtar H; Bickers DR
Biochem Biophys Res Commun; 1983 Jul; 114(1):388-94. PubMed ID: 6309171
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microsome-mediated binding of benzo[a]pyrene to DNA by flavonoids either in vitro or after dietary administration to rats.
Le Bon AM; Siess MH; Suschetet M
Chem Biol Interact; 1992 Jun; 83(1):65-71. PubMed ID: 1643669
[TBL] [Abstract][Full Text] [Related]
13. Ellagic acid: a potent naturally occurring inhibitor of benzo[a]pyrene metabolism and its subsequent glucuronidation, sulfation and covalent binding to DNA in cultured BALB/C mouse keratinocytes.
Mukhtar H; Del Tito BJ; Marcelo CL; Das M; Bickers DR
Carcinogenesis; 1984 Dec; 5(12):1565-71. PubMed ID: 6333937
[TBL] [Abstract][Full Text] [Related]
14. Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
Modly CE; Das M; Don PS; Marcelo CL; Mukhtar H; Bickers DR
Drug Metab Dispos; 1986; 14(4):413-6. PubMed ID: 2873987
[TBL] [Abstract][Full Text] [Related]
15. Regioselective inhibition of benzo(a)pyrene metabolism by corticosterone in comparison with metyrapone and alpha-naphthoflavone.
Bogdanffy MS; Roberts AE; Schatz RA; Brown DR
Toxicol Lett; 1986 Apr; 31(1):57-64. PubMed ID: 3715917
[TBL] [Abstract][Full Text] [Related]
16. Different patterns of benzo[a]pyrene metabolism of purified cytochromes P-450 from methylcholanthrene, beta-naphthoflavone and phenobarbital treated rats.
Gozukara EM; Guengerich FP; Miller H; Gelboin HV
Carcinogenesis; 1982; 3(2):129-33. PubMed ID: 6279326
[TBL] [Abstract][Full Text] [Related]
17. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
[TBL] [Abstract][Full Text] [Related]
18. The effects of cytochrome P-450-448 inhibitors on the binding of benzo(a)pyrene and derivatives to DNA upon microsomal activation.
Liu WI; Sloane NH
Xenobiotica; 1979 Mar; 9(3):165-71. PubMed ID: 38576
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
Wroblewski VJ; Gessner T; Olson JR
Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
[TBL] [Abstract][Full Text] [Related]
20. Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase.
Hu Z; Wells PG
Toxicol Appl Pharmacol; 1994 Aug; 127(2):306-13. PubMed ID: 8048075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
